Published in Lancet on June 25, 1977
The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99
Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J (1979) 2.02
Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol (2001) 1.99
Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest (1993) 1.20
The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients (2010) 1.18
Relative contributions of diet and sunlight to vitamin D state in the elderly. Br Med J (1979) 1.08
Evolution of the calcium paradigm: the relation between vitamin D, serum calcium and calcium absorption. Nutrients (2010) 1.06
Severe Hypocalcemia due to Vitamin D Deficiency after Extended Roux-en-Y Gastric Bypass. J Obes (2011) 1.03
Nonclassical vitamin D action. Nutrients (2010) 1.02
Vitamin D and inflammation. Dermatoendocrinol (2015) 0.94
Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res (2014) 0.88
A case of resolving idiopathic hypoparathyroidism. Postgrad Med J (1991) 0.85
Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. Arch Dis Child (1981) 0.83
Therapeutic applications of vitamin D analogues. Br Med J (1979) 0.81
Vitamin D and respiratory tract infections in childhood. BMC Infect Dis (2015) 0.80
Plasma 25-hydroxyvitamin D concentrations in preterm infants receiving oral vitamin D supplements. Arch Dis Child (1981) 0.77
Vitamin D transport in an infant with vitamin D toxicity. Br Med J (1978) 0.75
Treatment of the hepatic osteomalacia. Br Med J (1978) 0.75
Oral vitamin D supplementation at five times the recommended allowance marginally affects serum 25-hydroxyvitamin D concentrations in dogs. J Nutr Sci (2016) 0.75
Comment on Przybelski et al.: Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int (2009) 0.75
Vitamin D supplementation. CMAJ (1993) 0.75
Safety of 50,000-100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance. N Am J Med Sci (2016) 0.75
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocr Rev (2016) 0.75
Evaluation of vitamin D3 intakes up to 15,000 international units/day and serum 25-hydroxyvitamin D concentrations up to 300 nmol/L on calcium metabolism in a community setting. Dermatoendocrinol (2017) 0.75
Vitamin D₃ and 25-Hydroxyvitamin D₃ Content of Retail White Fish and Eggs in Australia. Nutrients (2017) 0.75
Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J (1970) 5.88
Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab (1971) 4.81
Vitamin D deficiency in homebound elderly persons. JAMA (1995) 3.09
Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature (1974) 2.95
The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest (1966) 2.92
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab (1986) 2.81
Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol (1991) 2.33
Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med (1972) 2.25
Human perinatal vitamin D metabolism. I. 25-Hydroxyvitamin D in maternal and cord blood. J Pediatr (1974) 2.17
Recessive hypophosphataemic rickets, and possible aetiology of the 'vitamin D-resistant' syndrome. Arch Dis Child (1976) 2.16
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest (1999) 2.02
Perinatal vitamin D metabolism. II. Serial 25-hydroxyvitamin D concentrations in sera of term and premature infants. J Pediatr (1975) 2.01
Spontaneous cure of vitamin-D deficiency in Asians during summer in Britain. Lancet (1974) 1.87
Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab (1999) 1.86
Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab (1985) 1.77
Letter: Anticonvulsant osteomalacia and vitamin D. Br Med J (1974) 1.77
Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br Med J (1972) 1.60
Effects of long-term anticonvulsant therapy on calcium and vitamin D metabolism. Proc R Soc Med (1974) 1.59
Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins. J Clin Invest (1972) 1.58
Circulating 25-hydroxyvitamin D in man. Am J Med (1974) 1.58
Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature (1973) 1.56
Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. J Clin Invest (1976) 1.56
Altered vitamin-D metabolism in pregnancy. Lancet (1977) 1.55
Iatrogenic osteomalacia and myopathy due to phosphate depletion. Br Med J (1974) 1.51
Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest (1984) 1.45
Treatment of osteolytic myelomatosis with mithramycin. Lancet (1975) 1.44
Cancellous bone volume and structure in the forearm: noninvasive assessment with MR microimaging and image processing. Radiology (1998) 1.42
Theoretical renal phosphorus threshold in investigation and treatment of osteomalacia. Lancet (1970) 1.41
Trial of oral flupirtine maleate in the treatment of pain after orthopaedic surgery. Curr Med Res Opin (1985) 1.40
25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein. J Biol Chem (1976) 1.39
Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev (1996) 1.36
Nutritional osteomalacia and late rickets in Greater London, 1974--1979: clinical and metabolic studies in 45 patients. Clin Endocrinol Metab (1980) 1.35
Hypophosphataemic osteomalacia presenting in adults. Q J Med (1971) 1.33
Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment. Clin Orthop Relat Res (1993) 1.27
Effects of prolonged thyrocalcitonin administration on Paget's disease of bone. N Engl J Med (1970) 1.27
Vitamin D binding protein (Gc-globulin). Endocr Rev (1989) 1.25
Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology (2000) 1.23
Bone disease in burn patients. J Bone Miner Res (1993) 1.23
Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response. Ann Intern Med (1977) 1.22
25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest (1975) 1.22
Glucocorticoid effects in vitamin D intoxication. Arch Intern Med (1979) 1.21
Serial measurements of serum calcium, magnesium, parathyroid hormone, calcitonin, and 25-hydroxy-vitamin D in premature and term infants during the first week of life. Pediatr Res (1977) 1.19
Widespread, specific binding of 25-hydroxycholecalciferol in rat tissues. J Biol Chem (1975) 1.17
Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin. J Biol Chem (1989) 1.16
Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest (1986) 1.16
Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration. J Clin Endocrinol Metab (1979) 1.15
Intestinal absorption of 25-hydroxycholecalciferol. Lancet (1974) 1.14
Treatment of primary hyperoxaluria. Arch Dis Child (1970) 1.13
Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects. Arch Biochem Biophys (1977) 1.13
Disruption of microfilament organization in living nonmuscle cells by microinjection of plasma vitamin D-binding protein or DNase I. Proc Natl Acad Sci U S A (1990) 1.11
Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab (1985) 1.11
"Rocket" immunoelectrophoresis assay of vitamin D-binding protein (Gc globulin) in human serum. Clin Chem (1982) 1.11
Perinatal vitamin D metabolism. III. Factors influencing late gestational human serum 25-hydroxyvitamin D. Am J Obstet Gynecol (1976) 1.09
Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol. J Clin Endocrinol Metab (1976) 1.08
Effect of chapattis and ultraviolet irradiation on nutritional rickets in an Indian immigrant. Lancet (1973) 1.07
Human serum binding protein for vitamin D and its metabolites (DBP): evidence that actin is the DBP binding component in human skeletal muscle. Arch Biochem Biophys (1982) 1.07
Severe osteoporosis in men. Ann Intern Med (1995) 1.02
Brevin and vitamin D binding protein: comparison of the effects of two serum proteins on actin assembly and disassembly. Biochemistry (1984) 1.01
Factors in human vitamin D nutrition and in the production and cure of classical rickets. Proc Nutr Soc (1975) 1.00
Vitamin D plasma binding protein. Turnover and fate in the rabbit. J Clin Invest (1981) 0.98
In vivo threshold for cutaneous synthesis of vitamin D3. J Lab Clin Med (1989) 0.98
Treatment of calcinosis circumscripta with probenecid. Br Med J (1972) 0.98
Human serum binding protein for vitamin D and its metabolites. II. Specific, high affinity association with a protein in nucleated tissue. J Biol Chem (1979) 0.97
Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations. J Clin Endocrinol Metab (1978) 0.97
Placental transfer of vitamin D3 and 25-hydroxycholecalciferol in the rat. J Lab Clin Med (1971) 0.97
The articular manifestations of Paget's disease of bone. A case report. Clin Orthop Relat Res (1992) 0.96
Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management. Rheumatology (Oxford) (2000) 0.95
Actin affinity chromatography in the purification of human, avian and other mammalian plasma proteins binding vitamin D and its metabolites (Gc globulins). Biochem J (1984) 0.95
Transport of vitamin D metabolites. Clin Orthop Relat Res (1980) 0.95
Comparison of glomerular filtration rate measurements using inulin, 51CrEDTA, and a phosphate infusion technique. Clin Chim Acta (1970) 0.94
Osteoporosis: clinical assessment with quantitative MR imaging in diagnosis. Radiology (1995) 0.94
Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis. J R Soc Med (1982) 0.93
Hypocalcemia and skeletal disease as presenting features of celiac disease. Arch Intern Med (1997) 0.93
Serum concentrations of 25-hydroxyvitamin D in sex-linked hypophosphatemic vitamin D-resistant rickets. J Lab Clin Med (1973) 0.90
Vitamin D metabolism. Recent advances. Arch Dis Child (1973) 0.90
Vitamin D binding protein sequesters monomeric actin in the circulation of the rat. J Clin Invest (1987) 0.90
Nondialyzable urinary hydroxyproline as an index of bone collagen formation. J Clin Endocrinol Metab (1970) 0.89
Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae. Endocrinology (1987) 0.89
Estrogen receptors in fracture healing. Clin Orthop Relat Res (1992) 0.89
Human serum binding protein for vitamin D and its metabolites. I. Physicochemical and immunological identification in human tissues. J Biol Chem (1979) 0.88
The adult presenting idiopathic Fanconi syndrome. J Inherit Metab Dis (1981) 0.88
Vitamin D metabolite-binding proteins in human tissue. Biochim Biophys Acta (1976) 0.87
Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). N Engl J Med (1988) 0.87
Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels. Diabetes (1969) 0.87
Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells. Immunology (1991) 0.87
Competition by 24,25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol. J Clin Endocrinol Metab (1976) 0.87
Vitamin D resistance in osteomalacia after ureterosigmoidostomy. N Engl J Med (1977) 0.87
Vitamin-D deficiency in the osteomalacia of chronic renal failure. Lancet (1976) 0.86
Hepatic accumulation of vitamin D3 and 25-hydroxyvitamin D3. Biochim Biophys Acta (1976) 0.86
Progress in endocrinology and metabolism. Vitamin D: current concepts. Metabolism (1973) 0.85
Vitamin D--solar rays, the Milky Way, or both? N Engl J Med (1992) 0.85
Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets. J Clin Endocrinol Metab (1975) 0.85
Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin. Lancet (1974) 0.85
Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): recognition of an epitope hidden in membranes of circulating monocytes. Endocrinology (1986) 0.84
Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy. J Lab Clin Med (1977) 0.84